To include your compound in the COVID-19 Resource Center, submit it here.

FDA approves mAb for multidrug-resistant HIV

FDA approved Trogarzo ibalizumab-uiyk, a humanized mAb against CD4 that prevents viral entry, to treat heavily treatment-experienced patients with HIV-1 whose

Read the full 216 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE